The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.846
Bid: 0.842
Ask: 0.85
Change: 0.006 (0.71%)
Spread: 0.008 (0.95%)
Open: 0.848
High: 0.85
Low: 0.842
Prev. Close: 0.84
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Apr 2017 15:45

RNS Number : 8417B
BioPharma Credit PLC
06 April 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

BioPharma Credit PLC

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Issue of New Shares

Yes

3. Full name of person(s) subject to thenotification obligation:

Pharmaceutical Investors LP

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

30 March 2017

6. Date on which issuer notified:

5 April 2017

7. Threshold(s) that is/are crossed orreached:

9%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct / Indirect

Direct

Indirect

Direct

Indirect

ORD USD0.01

Below 10%

Below 10%

71,990,100

71,990,100

9.4%

GB00BDGKMY29

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

71,990,100

9.4%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

George Lloyd

 

15. Contact telephone number:

+1-212-883-2275

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNASRBOASRAR
Date   Source Headline
15th Dec 20217:00 amRNSNEW INVESTMENTS OF UP TO US$112.5 MILLION
19th Nov 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
4th Nov 20217:00 amRNSDividend Declaration
21st Oct 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Oct 202111:39 amRNSDirector Declaration
8th Oct 20217:00 amRNSConfirmation of Delisting from TISE
5th Oct 20217:00 amRNSTransfer of Shares to the Premium Segment
30th Sep 20214:30 pmRNSResult of General Meeting
21st Sep 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
15th Sep 20217:00 amRNSHalf-yearly Report
13th Sep 20217:29 amRNSCREDIT FACILITY UPDATE
27th Aug 20215:30 pmRNSHolding(s) in Company
26th Aug 20215:00 pmRNSHolding(s) in Company
25th Aug 20217:00 amRNSNotice of Half Year Results
20th Aug 20214:00 pmRNSNet Asset Value(s)
19th Aug 20215:30 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDividend Declaration
10th Aug 20214:45 pmRNSHolding(s) in Company
21st Jul 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
24th Jun 20211:30 pmRNSResult of GM and AGM
21st Jun 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
17th Jun 20213:30 pmRNSResult of Annual General Meeting
4th Jun 20214:30 pmRNSNotice of GM and Change in Proposed Auditor
26th May 20214:00 pmRNSDividend Declaration
25th May 20213:45 pmRNSChange of Auditor
25th May 20213:30 pmRNSNotice of AGM
24th May 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
6th May 202110:30 amRNSDirector/PDMR Shareholding
23rd Apr 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Apr 202111:00 amRNSHolding(s) in Company
24th Mar 20217:00 amRNSNEW INVESTMENT
19th Mar 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Mar 20217:00 amRNSAnnual Financial Report
12th Mar 20215:00 pmRNSReplacement: Dividend Declaration
11th Mar 20215:15 pmRNSDividend Declaration
19th Feb 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
17th Feb 20217:00 amRNSNotice of Full Year Results
22nd Jan 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
31st Dec 202012:00 pmRNSDirector/PDMR Shareholding
21st Dec 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Nov 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Nov 20207:00 amRNSDividend Declaration
9th Nov 20207:00 amRNSADDITIONAL INVESTMENT IN EPIZYME
21st Oct 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th Oct 20203:30 pmRNSHolding(s) in Company
8th Oct 20202:00 pmRNSHolding(s) in Company
1st Oct 20204:45 pmRNSDirector/PDMR Shareholding
1st Oct 202011:00 amRNSDirector/PDMR Shareholding
1st Oct 202011:00 amRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSSTATEMENT REGARDING SAREPTA THERAPEUTICS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.